AstraZeneca advances plan for climate-friendly inhalers
Pharmaceutical giant is partnering with Honeywell to develop an inhaler propellant that has 99.9 percent less Global Warming Potential than current models. Read More
4 takeaways from GreenBiz 22
At GreenBiz's flagship annual conference, corporate leaders highlighted these focus areas, from investor engagement to net zero. Read More
Vanguard takes a baby step on climate change — finally
The $7 trillion silent member of the Big Three tags coal as a concern years behind other investors. Read More
Confronting the reality of inequitable access to recycling
Will investing in research, infrastructure and training improve the system? Read More
21 solutions to make our economy more circular
Instead of producing more things, we must maximize the use of existing ones. Read More
Climate change-fueled floods could cause 26% more damage in next 30 years
The annual cost of flooding today is over US$32 billion nationwide, with an outsized burden on communities in Appalachia, the Gulf Coast and the Northwest. Read More
Across the boreal forest, scientists are tracking warming’s tragic toll
Thawing permafrost, drowned trees, methane releases and increased wildfires, are slowly transforming Northern Forests from carbon sinks to carbon emitters. Read More
Carbon tunnel vision leads to missed opportunities in water
With all the focus on carbon, what are corporations doing on water? Read More
3 lessons from hosting our first mostly vegan conference
How did our attendees like our vegan menu? And what did we would we change for next time? Read More
Is the food sector moving away from carbon offsetting?
At GreenBiz 22, sustainability leaders talked about how carbon credits will play a role in their sustainability strategies. Read More